Source: Eyewire News

BostonSight: BostonSight Publishes Study Highlighting Prose Lens Utilization for Drug Delivery

BostonSight announced it has published a study: "Utilizing PROSE as a Drug Delivery Device for Preservative-Free Cyclosporine 0.05% for the

Read full article »
Est. Annual Revenue
$25-100M
Est. Employees
100-250
Sara Yost's photo - CEO of BostonSight

CEO

Sara Yost

CEO Approval Rating

- -/100

Read more